These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9226166)

  • 1. Orderly process of sequential cytokine stimulation is required for activation and maximal proliferation of primitive human bone marrow CD34+ hematopoietic progenitor cells residing in G0.
    Ladd AC; Pyatt R; Gothot A; Rice S; McMahel J; Traycoff CM; Srour EF
    Blood; 1997 Jul; 90(2):658-68. PubMed ID: 9226166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of proliferative and colony-forming capacity after successive in vitro divisions of single human CD34+ cells initially isolated in G0.
    Gothot A; Pyatt R; McMahel J; Rice S; Srour EF
    Exp Hematol; 1998 Jul; 26(7):562-70. PubMed ID: 9657130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice.
    Gothot A; van der Loo JC; Clapp DW; Srour EF
    Blood; 1998 Oct; 92(8):2641-9. PubMed ID: 9763545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential.
    Traycoff CM; Abboud MR; Laver J; Clapp DW; Srour EF
    Exp Hematol; 1994 Dec; 22(13):1264-72. PubMed ID: 7525328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human umbilical cord blood hematopoietic progenitor cells: are they the same as their adult bone marrow counterparts?
    Traycoff CM; Abboud MR; Laver J; Clapp DW; Hoffman R; Law P; Srour EF
    Blood Cells; 1994; 20(2-3):382-90; discussion 390-1. PubMed ID: 7538343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional heterogeneity of human CD34(+) cells isolated in subcompartments of the G0 /G1 phase of the cell cycle.
    Gothot A; Pyatt R; McMahel J; Rice S; Srour EF
    Blood; 1997 Dec; 90(11):4384-93. PubMed ID: 9373249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed targeting of cytokine-nonresponsive human bone marrow CD34(+) cells with retrovirus-mediated gene transfer enhances transduction efficiency and long-term expression of transduced genes.
    Veena P; Traycoff CM; Williams DA; McMahel J; Rice S; Cornetta K; Srour EF
    Blood; 1998 May; 91(10):3693-701. PubMed ID: 9573006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor.
    Lemoli RM; Tafuri A; Fortuna A; Petrucci MT; Ricciardi MR; Catani L; Rondelli D; Fogli M; Leopardi G; Ariola C; Tura S
    Blood; 1997 Feb; 89(4):1189-96. PubMed ID: 9028941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta regulates the cell cycle status of interleukin-3 (IL-3) plus IL-1, stem cell factor, or IL-6 stimulated CD34+ human hematopoietic progenitor cells through different cell kinetic mechanisms depending on the applied stimulus.
    Lardon F; Snoeck HW; Nijs G; Lenjou M; Peetermans ME; Rodrigus I; Berneman ZN; Van Bockstaele DR
    Exp Hematol; 1994 Aug; 22(9):903-9. PubMed ID: 7520393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34(+)CD38(low/neg) human bone marrow cells.
    Bennaceur-Griscelli A; Tourino C; Izac B; Vainchenker W; Coulombel L
    Blood; 1999 Jul; 94(2):529-38. PubMed ID: 10397720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15.
    Yu H; Fehniger TA; Fuchshuber P; Thiel KS; Vivier E; Carson WE; Caligiuri MA
    Blood; 1998 Nov; 92(10):3647-57. PubMed ID: 9808558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+ bone marrow progenitor cells in vitro.
    Rusten LS; Lyman SD; Veiby OP; Jacobsen SE
    Blood; 1996 Feb; 87(4):1317-25. PubMed ID: 8608220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FLT3 ligand preserves the uncommitted CD34+CD38- progenitor cells during cytokine prestimulation for retroviral transduction.
    Nielsen SD; Husemoen LL; Sørensen TU; Gram GJ; Hansen JE
    J Hematother Stem Cell Res; 2000 Oct; 9(5):695-701. PubMed ID: 11091493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation.
    Verfaillie CM
    Blood; 1993 Oct; 82(7):2045-53. PubMed ID: 7691246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porcine brain microvascular endothelial cells support the in vitro expansion of human primitive hematopoietic bone marrow progenitor cells with a high replating potential: requirement for cell-to-cell interactions and colony-stimulating factors.
    Davis TA; Robinson DH; Lee KP; Kessler SW
    Blood; 1995 Apr; 85(7):1751-61. PubMed ID: 7535587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flt3 ligand induces proliferation of quiescent human bone marrow CD34+CD38- cells and maintains progenitor cells in vitro.
    Shah AJ; Smogorzewska EM; Hannum C; Crooks GM
    Blood; 1996 May; 87(9):3563-70. PubMed ID: 8611678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of in vitro proliferation kinetics and primitive hematopoietic potential of individual human CD34+CD38-/lo cells in G0.
    Srour EF; Tong X; Sung KW; Plett PA; Rice S; Daggy J; Yiannoutsos CT; Abonour R; Orschell CM
    Blood; 2005 Apr; 105(8):3109-16. PubMed ID: 15613542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retention of quiescent hematopoietic cells with high proliferative potential during ex vivo stem cell culture.
    Young JC; Varma A; DiGiusto D; Backer MP
    Blood; 1996 Jan; 87(2):545-56. PubMed ID: 8555476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.